Funding
This research received no specific grant from any funding agency in the public, commercial, or not-for-profit sectors”
References
  1. Molimard M, Raherison C, Lignot S, et: Chronic obstructive pulmonary disease exacerbation and inhaler device handling: real-life assessment of 2935 patients. Eur Respir J. 2017, 49:1601794. doi: 10.1183/13993003.01794-2016.
  2. Sanchis J, Gich I, Pedersen S: Systematic review of errors in inhaler use: has patient technique improved over time?. Chest . 2016, 150:394-406. doi: 10.1016/j.chest.2016.03.041..
  3. Hess DR. Aerosol delivery devices in the treatment of asthma.Respir Care . 2008, 53: 699-723.
  4. Hesselink AE, Penninx BW, Wijnhoven HA, Kriegsman DM, van Eijk JT. Determinants of an incorrect inhalation technique in patients with asthma or COPD. Scand J Prim Health Care . 2001;19(4):255-60. doi: 10.1080/02813430152706792.
  5. Pedersen S, Frost L, Arnfred T. Errors in inhalation technique and efficiency in inhaler use in asthmatic children. Allergy . 1986;41(2):118-24. doi: 10.1111/j.1398-9995.1986.tb00287.x.
  6. Goren A, Noviski N, Avital A, Maayan C, Stahl E, Godfrey S, Springer C. Assessment of the ability of young children to use a powder inhaler device (Turbuhaler). Pediatr Pulmonol. 1994;18(2):77-80. doi: 10.1002/ppul.1950180204.
  7. Molimard M, Raherison C, Lignot S, Depont F, Abouelfath A, Moore N. Assessment of handling of inhaler devices in real life: an observational study in 3811 patients in primary care. J Aerosol Med . 2003;16(3):249-54. doi: 10.1089/089426803769017613.
  8. Connett GJ, Warde C, Wooler E, Lenny W: Use of budesonide in severe asthmatic aged 1-3 years. Arch Dis Child . 1993; 69:351-355. doi: 10.1136/adc.69.3.351.
  9. Luczak-Wozniak K, Dabrowska M, Domagala I, Miszczuk M, Lubanski W, Leszczynski A, Krenke R: Mishandling of pMDI and DPI inhalers in asthma and COPD - repetitive and non-repetitive errors. Pulm Pharmacol Ther . 2018; 51:65- 2. doi: 10.1016/j.pupt.2018.06.002.
  10. Crane MA, Jenkins CR, Goeman DP, Douglass JA: Inhaler device technique can be improved in older adults through tailored education: findings from a randomized controlled trial. NPJ Prim Care Respir Med . 2014, 24:14034. doi: 10.1038/npjpcrm.2014.34.
  11. Hindle M, Chrystyn H. Determination of the relative of salbutamol to the lung following inhalation. Br J Clin Pharmacol 1992; 34: 311–315. doi: 10.1111/j.1365-2125.1992.tb05921.x.
  12. Tomlinson HS, Corlett SA, Chrystyn H. Dose-response relationship and reproducibility of urinary salbutamol excretion during the first 30 min after inhalation. Br J Clin Pharmacol. 2003; 56(2):225-7. doi: 10.1046/j.1365-2125.2003.01864.x.
  13. Hindle M, Chrystyn H: Relative bioavailability of salbutamol to the lung following inhalation using metered-dose inhalation methods and spacer devices. Thorax . 1994, 49: 549-553. doi: 10.1136/thx.49.6.549.
  14. Hindle M, Newton DA, Chrystyn H. Investigations of an optimal inhaler technique with the use of urinary salbutamol excretion as a measure of relative bioavailability to the lung. Thorax . 1993 Jun;48(6):607-10.  doi: 10.1136/thx.48.6.607.
  15. Du XL, Zhu Z, Fu Q, Li DK, Xu WB. Pharmacokinetics and relative bioavailability of salbutamol metered-dose inhaler in healthy volunteers. Acta Pharmacol Sin . 2002 Jul;23(7):663-6.
  16. Chege JK, Chrystyn H. Volumatic usage: some generic salbutamol metered-dose inhalers can be used. Thorax 1994;49: 1162–1163. doi: 10.1136/thx.49.11.1162.
  17. Singh D, Agusti A, Anzueto A, Barnes PJ, Bourbeau J, Celli BR. Et al. Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease: the GOLD science committee report 2019. Eur Respir J . 2019;53(5):1900164. doi: 10.1183/13993003.00164-2019.
  18. Ministry of Health. Vietnamese Guideline for Diagnosis and Treatment of Chronic Obstructive Pulmonary Disease. 2015. (No 2866/QĐ-BYT). Hanoi: Medical Publishing House; 2015.
  19. Sanchis J, Corrigan C, Levy ML, Viejo JL; ADMIT Group. Inhaler devices – from theory to practice. Respir Med. 2013;107(4):495–502. doi: 10.1016/j.rmed.2012.12.007.
  20. Batterink J, Dahri K, Aulakh A, Rempel C. Evaluation of the use of inhaled medications by hospital inpatients with chronic obstructive pulmonary disease. Can J Hosp Pharm . 2012;65(2):111–118. doi: 10.4212/cjhp.v65i2.1118.
  21. Basheti IA, Armour CL, Bosnic-Anticevich SZ, Reddel HK. Evalua­tion of a novel educational strategy, including inhaler-based reminder labels, to improve asthma inhaler technique. Patient Educ Couns . 2008;72(1):26–33. doi: 10.1016/j.pec.2008.01.014.
  22. Lewis LD, McLaren M, Essex E, Cochrane GM. Plasma concentrations of salbutamol in acute severe asthmatics. Aust N Z J Med . 1990;20(3):204-7. doi: 10.1111/j.1445-5994.1990.tb01019.x.
  23. Horn CR, Essex E, Hill P, Cochrane GM. Does urinary salbutamol reflect compliance with the aerosol regimen in patients with asthma?Respir Med . 1989;83(1):15-8.  doi: 10.1016/s0954-6111(89)80054-x.
  24. Silkstone VL, Corlett SA, Chrystyn H. Determination of the relative bioavailability of salbutamol to the lungs and systemic circulation following nebulization. Br J Clin Pharmacol. 2002 Aug;54(2):115-9. doi: 10.1046/j.1365-2125.2002.01632.x.
  25. Chege JK, Chrystyn H. The relative bioavailability of salbutamol to the lung using urinary excretion following inhalation from a novel dry powder inhaler: the effect of inhalation rate and formulation.Respir Med . 2000 Jan;94(1):51-6.  doi: 10.1053/rmed.1999.0692.
  26. Al-Showair RA, Tarsin WY, Assi KH, Pearson SB, Chrystyn H. Can all patients with COPD use the correct inhalation flow with all inhalers and does training help? Respir Med . 2007;101:2395–401. doi: 10.1016/j.rmed.2007.06.008.
  27. Lavorini F, Magnan A, Christophe Dubus J, Voshaar T, Corbetta L, Broeders M, Dekhuijzen R, Sanchis J, Viejo JL, Barnes P, et al. Effect of incorrect use of dry powder inhalers on management of patients with asthma and COPD. Respir Med. 2008;102:593–604. doi: 10.1016/j.rmed.2007.11.003.
  28. Göriş S, Taşci S, Elmali F. The effects of training on inhaler technique and quality of life in patients with COPD. J Aerosol Med Pulm Drug Deliv . 2013;26(6):336-44. doi: 10.1089/jamp.2012.1017.
  29. Sanchis J, Gich I, Pedersen S, Systematic review of errors in inhaler use: has patient technique improved over time? Chest.  2016; 150: 394–406. doi: 10.1016/j.chest.2016.03.041.
  30. Griffith MF, Feemster LC, Donovan LM, Spece LJ, Krishnan JA, Lindenauer PK, McBurnie MA, Mularski RA, Au DH. Poor Metered-Dose Inhaler Technique Is Associated with Overuse of Inhaled Corticosteroids in Chronic Obstructive Pulmonary Disease. Ann Am Thorac Soc . 2019;16(6):765-768.  doi: 10.1513/AnnalsATS.201812-889RL.